(Q36619556)

15 August 2017

1 reference

title

Mechanism of homeostatic regulation of tissue growth and reversion of transformed cells to nonmalignancy: a yin-yang problem (English)

1 reference

15 August 2017

Mechanism of Homeostatic Regulation of Tissue Growth and Reversion of Transformed Cells to Nonmalignancy: A Yin—Yang Problem (English)

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

3 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703193

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

3 November 2022

author name string

C. Chany

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703193

3 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1703193

3 November 2022

publication date

1 October 1990

1 reference

full work available at URL

15 August 2017

http://www.liebertpub.com/doi/pdf/10.1089/jir.1990.10.453

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Journal of Interferon Research

3 November 2022

published in

1 reference

15 August 2017

volume

10

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

453-459

1 reference

An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis

15 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Dual control of cell growth by somatomedins and platelet-derived growth factor

3 November 2022

2

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells

3 November 2022

3

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

3 November 2022

4

47

6413

FERRERO D.

1987

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Apparent role of the macrophage growth factor, CSF-1, in placental development

3 November 2022

5

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon

3 November 2022

7

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Unusual apparently constitutive interferons and antagonists in human placental blood

3 November 2022

8

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1

3 November 2022

9

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Detection of an interferon antagonist, sarcolectin, in human sarcomas and muscles

3 November 2022

10

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Identification of an interferon in murine placentas

3 November 2022

13

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Unusual human interferons produced by virus-infected amniotic membranes

3 November 2022

15

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Peptide growth factors are multifunctional

3 November 2022

18

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Effect of Prolonged Interferon Treatment on Mouse Embryonic Fibroblasts Transformed by Murine Sarcoma Virus

3 November 2022

20

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Partial reversion of the transformed phenotype of murine sarcoma virus-transformed cells in the presence of interferon: a possible mechanism for the anti-tumour effect of interferon.

3 November 2022

21

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

3 November 2022

22

41

4174

BROUTY-BOYE D.

1981

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon

3 November 2022

23

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

3 November 2022

24

49

1241

GERFAUX J.

1989

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Bovine leukocyte interferon: characterization and large-scale production

3 November 2022

28

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Growth factors, oncogenes, and multistage carcinogenesis

3 November 2022

29

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

3 November 2022

30

49

1008

ESTERVIG D.

1989

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

Alpha interferon for induction of remission in hairy-cell leukemia

3 November 2022

31

1 reference

https://api.crossref.org/works/10.1089/JIR.1990.10.453

3 November 2022

Identifiers

0 references

1 reference